| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |